Galapagos N.V. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
76,625.00
69,368.00
39,563.00
129,519.00
127,087.00
288,836
SG&A Expense
105,043.00
121,328.00
146,621.00
158,920.00
241,435.00
357,571
EBIT
-
56,609.00
110,460.00
31,254.00
118,633.00
73,816
Unusual Expense
290.00
669.00
30,632.00
57,479.00
-
1,203
Non Operating Income/Expense
19,820.00
21,137.00
20,447.00
26,645.00
1,486.00
33,447
Interest Expense
272.00
215.00
228.00
238.00
1,405.00
1,562
Pretax Income
16,135.00
35,201.00
119,627.00
54,246.00
115,507.00
35,509
Income Tax
676.00
2,102.00
1,217.00
234.00
197.00
6,250
Consolidated Net Income
16,811.00
37,303.00
118,410.00
54,012.00
115,704.00
29,259
Net Income
16,811.00
37,303.00
118,410.00
54,012.00
115,704.00
29,259
Net Income After Extraordinaries
25,543.00
107,817.00
118,410.00
54,012.00
115,704.00
29,259
Net Income Available to Common
8,079.00
34,297.00
118,410.00
54,012.00
115,704.00
29,259
EPS (Basic)
0.28
1.10
3.32
1.18
2.34
0.56
Basic Shares Outstanding
28,787.00
30,108.00
35,700.00
45,696.00
49,479.00
52,113
EPS (Diluted)
0.28
1.10
3.32
1.14
2.34
0.56
Diluted Shares Outstanding
28,787.00
30,108.00
35,700.00
47,308.00
49,479.00
52,113
EBITDA
28,418.00
51,960.00
107,058.00
27,072.00
114,348.00
68,735
Other Operating Expense
-
-
-
2,329.00
-
-
Non-Operating Interest Income
1,179.00
1,155.00
1,246.00
1,614.00
3,045.00
5,219

About Galapagos

View Profile
Address
Industriepark Mechelen Noord
Mechelen BU 2800
Belgium
Employees -
Website http://www.glpg.com
Updated 07/08/2019
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.